Congenital disorder of glycosylation

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Supportive / diluent 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Glycomine Inc. Commercial
    ALFA-D-MANNOSE 1-PHOSPHATE DIPOTASSIUM; SODIUM CHLORIDE
    2024-520109-37-00 8 countries 2025 n=45 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Glycomine Inc. Commercial 1 Phase II 0
New trials by year
2025
1
← All indication landscapes